With 0.69 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.5 million shares. The 52-week range on ERO shows that it touched its highest point at $23.40 and its lowest point at $9.30 during that stretch. It currently has a 1-year price target of $19.08. Beta for the stock currently stands at 1.28.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ERO was up-trending over the past week, with a rise of 0.13%, but this was up by 16.45% over a month. Three-month performance surged to 20.24% while six-month performance rose 9.30%. The stock lost -24.04% in the past year, while it has gained 17.66% so far this year. A look at the trailing 12-month EPS for ERO yields 0.18 with Next year EPS estimates of 2.91. For the next quarter, that number is 0.46. This implies an EPS growth rate of 181.20% for this year and 32.54% for next year.
Float and Shares Shorts:
At present, 103.57 million ERO shares are outstanding with a float of 94.48 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ERO since 11 analysts follow the stock currently. There are 9 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 2 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $1.08382 being high and $0.59956 being low. For ERO, this leads to a yearly average estimate of $0.81479.
